Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
13 Bekeken
• 07/13/23
0
0
insluiten
administrator
abonnees
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties